133 related articles for article (PubMed ID: 1691960)
21. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.
Minich WB; Lenzner C; Morgenthaler NG
Clin Exp Immunol; 2004 Apr; 136(1):129-36. PubMed ID: 15030524
[TBL] [Abstract][Full Text] [Related]
23. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
Strakosch CR; Joyner D; Manley SW; Wall JR
Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
[TBL] [Abstract][Full Text] [Related]
24. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
25. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
26. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
[TBL] [Abstract][Full Text] [Related]
27. [Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach].
Akamizu T; Kosugi S; Kohn LD; Mori T
Nihon Rinsho; 1994 Apr; 52(4):1024-30. PubMed ID: 7515117
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of immunogenic regions in TSH receptor for Graves' IgG and Hashimoto's IgG].
Murakami M; Miyashita K; Mori M
Nihon Rinsho; 1994 Apr; 52(4):1057-62. PubMed ID: 8196164
[TBL] [Abstract][Full Text] [Related]
29. Graves' disease: immunological and immunogenetic indicators of relapse.
de Bruin TW; Bolk JH; Bussemaker JK; Stijnen T; Schreuder GM; de Vries RR; van der Heide D
Br Med J (Clin Res Ed); 1988 May; 296(6632):1292-5. PubMed ID: 3133054
[TBL] [Abstract][Full Text] [Related]
30. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
31. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies.
Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J
Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477
[TBL] [Abstract][Full Text] [Related]
32. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
[TBL] [Abstract][Full Text] [Related]
33. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies.
Teale E; Gouldesbrough DR; Peacey SR
Thyroid; 2006 Aug; 16(8):791-3. PubMed ID: 16910883
[TBL] [Abstract][Full Text] [Related]
34. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
35. [Thyroid autoantibodies].
Le NH; Ballieux BE; Corssmit EP
Ned Tijdschr Geneeskd; 2015; 159():A8802. PubMed ID: 26104003
[TBL] [Abstract][Full Text] [Related]
36. Antithyrotropin antibodies in the sera of Graves' disease patients.
Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
[TBL] [Abstract][Full Text] [Related]
37. Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease.
Aizawa Y; Yoshida K; Kaise N; Kaise K; Fukazawa H; Kiso Y; Mori K; Sayama N; Kikuchi K; Abe K
Clin Endocrinol (Oxf); 1995 May; 42(5):517-22. PubMed ID: 7621571
[TBL] [Abstract][Full Text] [Related]
38. Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis.
Kraiem Z; Lahat N; Glaser B; Baron E; Sadeh O; Sheinfeld M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):409-21. PubMed ID: 2830061
[TBL] [Abstract][Full Text] [Related]
39. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease.
Heyma P; Harrison LC; Robins-Browne R
Clin Exp Immunol; 1986 May; 64(2):249-54. PubMed ID: 3017619
[TBL] [Abstract][Full Text] [Related]
40. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
